We are live on ! Find out more
CODX

Co-Diagnostics
CODX

43 hedge funds and large institutions have $4.83M invested in Co-Diagnostics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

266% more call options, than puts

Call options by funds: $172K | Put options by funds: $47K

0% more funds holding

Funds holding: 43 → 43 (0)

0% less ownership

Funds ownership: 0.49% → 0.49% (-0%)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

2% less capital invested

Capital invested by funds: $4.93M → $4.83M (-$94.9K)

36% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 11

Holders
43
Holders Change
–
Holders Change %
0%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
11
Closed
5
Calls
$172K
Puts
$47K
Net Calls
+$125K
Net Calls Change
+$10K

Top Buyers

Rank Fund Capital Flow
1
KAS
Kestra Advisory Services
Texas
+$84.4K
2
KOC
Koss-Olinger Consulting
Florida
+$58.9K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$56.6K
4
Jane Street
Jane Street
New York
+$32.5K
5
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$30.6K

Top Sellers

Rank Fund Capital Flow
1
Man Group
Man Group
United Kingdom
-$93.3K
2
First Trust Advisors
First Trust Advisors
Illinois
-$90.1K
3
Renaissance Technologies
Renaissance Technologies
New York
-$21.8K
4
American Century Companies
American Century Companies
Missouri
-$12.6K
5
Morgan Stanley
Morgan Stanley
New York
-$10.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$11.7K -$151 -4 -1%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$11.2K – – –
PNC Financial Services Group
28
PNC Financial Services Group
Pennsylvania
$4.24K – – –
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$3.27K – – –
GRP
30
Global Retirement Partners
California
$3.09K – – –
TRCT
31
Tower Research Capital (TRC)
New York
$2.95K +$2.68K +71 +323%
Wells Fargo
32
Wells Fargo
California
$2.44K -$4.65K -123 -62%
Osaic Holdings
33
Osaic Holdings
Arizona
$2.29K +$604 +16 +29%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$1.03K – – –
Fidelity Investments
35
Fidelity Investments
Massachusetts
$811 +$38 +1 +4%
HWA
36
Heritage Wealth Advisors
Virginia
$557 – – –
NA
37
NewEdge Advisors
Louisiana
$212 – – –
National Bank of Canada
38
National Bank of Canada
Quebec, Canada
$206 – – –
Group One Trading
39
Group One Trading
Illinois
$153 +$189 +5 New
UBS Group
40
UBS Group
Switzerland
$106 -$1.44K -38 -93%
JMF
41
Johnson Midwest Financial
Iowa
$106 – – –
JP Morgan Chase
42
JP Morgan Chase
New York
$81 – – –
Qube Research & Technologies (QRT)
43
Qube Research & Technologies (QRT)
United Kingdom
$14 – – –
HI
44
Harbour Investments
Wisconsin
$11 – – –
First Trust Advisors
45
First Trust Advisors
Illinois
– -$90.1K -2,706 Closed
American Century Companies
46
American Century Companies
Missouri
– -$12.6K -380 Closed
Federated Hermes
47
Federated Hermes
Pennsylvania
– -$3.03K -91 Closed
FHA
48
First Horizon Advisors
Tennessee
– -$1.55K -47 Closed
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
– -$264 -7 -50%
NMG
50
New Millennium Group
Utah
– -$13 – –
1
2

CODX Hedge Fund Activity: Q3 2023 in Review

43 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q3 2023, worth a combined $4.83M — down 1.9% from $4.93M a quarter earlier.

Fund positioning in CODX was balanced in Q3 2023: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 11 trimmed.

The largest buyer was Kestra Advisory Services, adding an estimated $84.4K. The largest seller was Man Group, exiting entirely with an estimated $93.3K sold.

  • 43 institutional investors held Co-Diagnostics (CODX) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $4.83M of Co-Diagnostics stock for Q3 2023, down 1.9% quarter-over-quarter.
  • 5 funds opened new Co-Diagnostics positions in Q3 2023 and 5 closed out, a net change of 0 holders.
  • The largest Co-Diagnostics buyer in Q3 2023 was Kestra Advisory Services, an estimated $84.4K added.
  • The largest Co-Diagnostics seller in Q3 2023 was Man Group, an estimated $93.3K sold.

Based on aggregated 13F filings for Q3 2023.